Paediatric HIV-1 infection: updated strategies of prevention mother-to-child transmission

References

• Luzuriaga K, Mofenson L. Challenges in the elimination of pediatric HIV-1 infection. N Engl J Med. 2016;374:761–70.10.1056/NEJMra1505256
   PubMed Web of Science ®Google Scholar
• Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1:a006841.
   PubMed Web of Science ®Google Scholar
• World Health Organization. People living with HIV by WHO region 2016; [cited 2016 Oct 3]. Available from: http://www.who.int/hiv/data/en/
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Ending AIDS, Progress towards the 90–90–90 targets 2017; [cited 2016 Oct 3]. Available from: http://unaids.org
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. AIDS by the numbers 2016; cited 2016 Oct 3. Available from: http://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-numbers-2016_en.pdf
   Google Scholar
• Writing group for the Kids to Adults Working. Group and data management and harmonisation group in EuroCoord. Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future. Euro Surveill. 2016;21:30162.
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2015; [cited 2017 Mar 21]. Available from: http://ecdc.europa.eu/en/publications/Publications/HIV-AIDS-surveillance-Europe-2015.pdf
   Google Scholar
• European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2017; [cited 2018 Jan 29]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/20171127-Annual_HIV_Report_Cover%2BInner.pdf
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Fact sheet – latest statistics on the status of the AIDS epidemic 2016; [cited 2016 Oct 3]. Available from: http://www.unaids.org/en/resources/fact-sheet
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive; [cited 2017 Jun 4]. Available from: http://www.unaids.org/sites/default/files/documents/JC2681_2014-Global-Plan-progress_en.pdf
   Google Scholar
• Sankar MJ, Sinha B, Chowdhury R, Bhandari N, Taneja S, Martines J, et al. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Paediatr. 2015;104:3–13.10.1111/apa.2015.104.issue-S467
   PubMed Web of Science ®Google Scholar
• Kiragu K, Collins L, Von Zinkernagel D, Mushavi A. Integrating PMTCT into maternal, newborn, and child health and related services. J Acquir Immune DeficSyndr. 2017;75:S36–S42.10.1097/QAI.0000000000001323
   PubMed Web of Science ®Google Scholar
• Petropoulou H, Stratigos AJ, Katsambas AD. Human immunodeficiency virus infection and pregnancy. Clin Dermatol. 2006;24:536–42.10.1016/j.clindermatol.2006.05.003
   PubMed Web of Science ®Google Scholar
• Chiappini E, Galli L, Lisi C, Gabiano C, Giaquinto C, Giacomet V, et al. Risk of perinatal HIV infection in infants born in Italy to immigrant mothers. Clin Infect Dis. 2011;53:310–13.10.1093/cid/cir344
   PubMed Web of Science ®Google Scholar
• Rakhmanina NY, Sill A, Baghdassarian A, Bruce K, Williams K, Castel AD, et al. Epidemiology of new cases of HIV-1 infection in children referred to the metropolitan pediatric hospital in Washington, DC. Pediatr Infect Dis J. 2008;27:837–9.10.1097/INF.0b013e3181719fa5
   PubMed Web of Science ®Google Scholar
• Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, et al. Factors associated with mother‐to‐child transmission of HIV‐1 despite a maternal viral load <500 copies/ml at delivery: a case‐control study nested in the French perinatal cohort (EPF‐ANRS CO1). Clin Infect Dis. 2010;50:585–96.10.1086/649511
   PubMed Web of Science ®Google Scholar
• Palladino C, Bellón JM, Jarrín I, Gurbindo MD, De José MI, Ramos JT, et al. Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980–2006. AIDS Res Hum Retroviruses. 2009;25:1091–7.10.1089/aid.2009.0070
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive; [cited 2017 Jun 4]. Available from: http://www.unaids.org/sites/default/files/documents/JC2681_2014-Global-Plan-progress_en.pdf
   Google Scholar
• Sankar MJ, Sinha B, Chowdhury R, Bhandari N, Taneja S, Martines J, et al. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Paediatr. 2015;104:3–13.10.1111/apa.2015.104.issue-S467
   PubMed Web of Science ®Google Scholar
• White AB, Mirjahangir JF, Horvath H, Anglemyer A, Read JS. Antiretroviral interventions for preventing breast milk transmission of HIV. Cochrane Database Syst Rev. 2014;10:CD011323.
   Google Scholar
• Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119–29.10.1056/NEJMoa0801941
   PubMed Web of Science ®Google Scholar
• David S, Abbas-Chorfa F, Vanhems P, Vallin B, Iwaz J, Ecochard R. Promotion of WHO feeding recommendations: a model evaluating the effects on HIV-free survival in African children. J Hum Lact. 2008;24:140–9.10.1177/0890334408315330
   PubMed Web of Science ®Google Scholar
• Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008;359:130–41.10.1056/NEJMoa073788
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, AIDS info. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States 2016; [cited 2017 Mar 4]. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf
   Google Scholar
• Bartlett JG, ACOG committee opinion. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Hopkins HIV Rep. 1999;11:7.
   PubMedGoogle Scholar
• Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med. 1999;341:394–402.10.1056/NEJM199908053410602
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/mL. J Infect Dis. 2001;183:539–45.10.1086/jid.2001.183.issue-4
   PubMed Web of Science ®Google Scholar
• Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS. 2008;22:973–81.10.1097/QAD.0b013e3282f9b67a
   PubMed Web of Science ®Google Scholar
• Raffe S, Curtis H, Tookey P, Peters H, Freedman A, Gilleece Y, British HIV. UK national clinical audit: management of pregnancies in women with HIV. BMC Infect Dis. 2017;17:665.10.1186/s12879-017-2255-6
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, AIDSinfo. When to start antiretroviral therapy 2017; [cited 2017 Mar 22]. Available from: https://aidsinfo.nih.gov/education-materials/fact-sheets/21/52/when-to-start-antiretroviral-therapy
   Google Scholar
• Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173–80.10.1056/NEJM199411033311801
   PubMed Web of Science ®Google Scholar
• Cooper ER, Nugent RP, Diaz C, Pitt J, Hanson C, Kalish LA, et al. After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis. 1996;174:1207–11.10.1093/infdis/174.6.1207
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015; [cited 2017 Mar 4]. Available from: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf
   Google Scholar
• Raffe SF, Savage C, Perry LA, Patel A, Keith T, Howell R, et al. The management of HIV in pregnancy: a 10-year experience. Eur J Obstet Gynecol Reprod Biol. 2017;210:310–13.10.1016/j.ejogrb.2016.12.021
   PubMed Web of Science ®Google Scholar
• Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. N Engl J Med. 2016;375:1726–1737.10.1056/NEJMoa1511691
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015; [cited 2017 Mar 4]. Available from: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf
   Google Scholar
• Sollai S, Noguera-Julian A, Galli L, Fortuny C, Deyà Á, de Martino M, et al. Strategies for the prevention of mother to child transmission in western countries. Pediatr Infect Dis J. 2015;34:S14–S30.10.1097/INF.0000000000000661
   PubMed Web of Science ®Google Scholar
• Ding Y, Duan S, Wu Z, Ye R, Yang Y, Yao S, et al. Timing of antiretroviral therapy initiation after diagnosis of recent human immunodeficiency virus infection and CD4(+) T-cell recovery. Clin Microbiol Infect. 2016;22:290.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The use of antiretroviral drugs for treating and preventing HIV infection 2016; [cited 2017 Mar 24]. Available from: http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf?ua=1
   Google Scholar
• French CE, Thorne C, Byrne L, Cortina-Borja M, Tookey PA. Presentation for care and antenatal management of HIV in the UK, 2009–2014. HIV Med. 2017;18:161–70.10.1111/hiv.12410
   PubMed Web of Science ®Google Scholar
• United Nations Children’s Fund. UNICEF option B and option B+: key considerations for countries to implement an equity-focused approach 2012; [cited 2017 Mar 5]. Available from: https://www.unicef.org/aids/files/hiv_Key_considerations_options_B.pdf
   Google Scholar
• Siegfried N, Van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011;7:CD003510.
   Google Scholar
• World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach 2010; [cited 2017 Sep 24]. Available from: http://apps.who.int/iris/bitstream/10665/75236/1/9789241599818_eng.pdf
   Google Scholar
• Bera E, Mia R. Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: a systematic review and meta-analysis. South Afr Medi J. 2012;102:855–9.10.7196/SAMJ.5700
   PubMed Web of Science ®Google Scholar
• World Health Organization. The use of antiretroviral drugs for treating and preventing HIV infection 2013; [cited 2017 Mar 4]. Available from: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf
   Google Scholar
• World Health Organization. Summary of new recommendations, consolidated ARV guidelines 2013; [cited 2017 Sep 24]. Available from: http://www.who.int/hiv/pub/guidelines/arv2013/intro/summarynewrecommendations.pdf?ua=1
   Google Scholar
• World Health Organization. First PROMISE study results confirm WHO recommendations to treat pregnant women and reduce mother-to-child-transmission of HIV 2016; [cited 2017 Mar 5]. Available from: http://www.who.int/hiv/mediacentre/news/promise-study-result/en/
   Google Scholar
• Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. N Engl J Med. 2016;375:1726–37.10.1056/NEJMoa1511691
   PubMed Web of Science ®Google Scholar
• Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis. 2012;206:1695–1705.10.1093/infdis/jis553
   PubMed Web of Science ®Google Scholar
• Papp E, Mohammadi H, Loutfy MR, Yudin MH, Murphy KE, Walmsley SL, et al. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction. J Infect Dis. 2015;211:10–8.10.1093/infdis/jiu393
   PubMed Web of Science ®Google Scholar
• Siemieniuk RAC, Lytvyn L, Mah Ming J, Mullen RM, Anam F, Otieno T, et al. Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline. BMJ. 2017;358:j3961.10.1136/bmj.j3961
   PubMedGoogle Scholar
• British HIV Association. Guidelines for the management of HIV infection in pregnant women 2012. HIV Med. 2012;13:87–157.
   PubMed Web of Science ®Google Scholar
• Knapp KM, Brogly SB, Muenz DG, Spiegel HM, Conway DH, Scott GB, et al. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J. 2012;31:164–70.10.1097/INF.0b013e318235c7aa
   PubMed Web of Science ®Google Scholar
• Nightingale SL. From the food and drug administration. JAMA. 1998;280:1472.10.1001/jama.280.17.1472-JFD80010-3-1
   PubMedGoogle Scholar
• De Santis M, Carducci B, De Santis L, Cavaliere AF, Straface G. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med. 2002;162:355.10.1001/archinte.162.3.355
   PubMed Web of Science ®Google Scholar
• World Health Organization. Use of efavirenz during pregnancy: a public health perspective. Technical update on treatment optimization 2012; [cited 2017 Sep 15]. Available from: http://apps.who.int/iris/bitstream/10665/70920/1/9789241503792_eng.pdf
   Google Scholar
• Zash R, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, et al. Comparative safety of antiretroviral treatment regimens in pregnancy. JAMA Pediatr. 2017;171:e172222. 10.1001/jamapediatrics.2017.2222
   PubMed Web of Science ®Google Scholar
• World Health Organization. First-line ART for pregnant and breastfeeding women and ARV drugs for their infants 2013; [cited 2017 Mar 4]. Available from: http://www.who.int/hiv/pub/guidelines/arv2013/art/artpregnantwomen/en/index3.html
   Google Scholar
• Viganò A, Mora S, Giacomet V, Stucchi S, Manfredini V, Gabiano C, et al. In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers. Antivir Ther. 2011;16:1259–66.
   PubMed Web of Science ®Google Scholar
• Siberry GK, Williams PL, Mendez H, Seage GR 3rd, Jacobson DL, Hazra R, et al. Pediatric HIV/AIDS Cohort Study (PHACS). Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS. 2012;26:1151–9.10.1097/QAD.0b013e328352d135
   PubMed Web of Science ®Google Scholar
• Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, Moffat C, et al. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr. 2011;56:428–36.10.1097/QAI.0b013e31820bd2b6
   PubMed Web of Science ®Google Scholar
• Rovira N, Noguera-Julian A, Rives S, Berrueco R, Lahoz R, Fortuny C. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants. Eur J Pediatr. 2016;175:1013–17.10.1007/s00431-016-2730-x
   PubMed Web of Science ®Google Scholar
• Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS. 2003;17:2053–61.10.1097/00002030-200309260-00006
   PubMed Web of Science ®Google Scholar
• Polo Rodríguez R, MuñozGalligo E, Iribarren JA, Domingo Pedrol P, Leyes García M, MaiquesMontesinos V, et al. Consensus statement on monitoring of HIV: pregnancy, birth, and prevention of mother-to-child transmission. Enferm Infecc Microbiol Clin. 2014;32:310.
   PubMed Web of Science ®Google Scholar
• Chiappini E, Berti E, Gianesin K, Petrara MR, Galli L. Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era. Cancer Lett. 2014;347:38–45.10.1016/j.canlet.2014.02.002
   PubMed Web of Science ®Google Scholar
• Poirier MC, Olivero OA, Walker DM, Walker VE. Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol. 2004;199:151–61.10.1016/j.taap.2003.11.034
   PubMed Web of Science ®Google Scholar
• Olivero OA. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen. 2007;48:215–23.10.1002/(ISSN)1098-2280
   PubMed Web of Science ®Google Scholar
• Walker VE, Poirier MC. Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen. 2007;48:159–65.10.1002/(ISSN)1098-2280
   PubMed Web of Science ®Google Scholar
• Olivero OA, Yuspa SH, Poirier MC, Anderson LM, Jones AB, Wang C, et al. Transplacental effects of 3’-azido-2’,3’-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst. 1997;89:1602–8.10.1093/jnci/89.21.1602
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access 2010; [cited 2017 Apr 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK138576/pdf/Bookshelf_NBK138576.pdf
   Google Scholar
• Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, et al. Antiretroviral therapies in pregnancy: maternal, foetal and neonatal effects. AIDS. 1998;12:F241–F247.10.1097/00002030-199818000-00002
   PubMed Web of Science ®Google Scholar
• The European Collaborative Study and the Swiss Mother, and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS. 2000;14:2913–20.
   PubMed Web of Science ®Google Scholar
• Short CE, Douglas M, Smith JH, Taylor GP. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission. HIV Med. 2014;15:233–8.10.1111/hiv.12083
   PubMed Web of Science ®Google Scholar
• Sibiude J, Warszawski J, Tubiana R, Dollfus C, Faye A, Rouzioux C, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis. 2012;54:1348–60.10.1093/cid/cis198
   PubMed Web of Science ®Google Scholar
• Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002;346:1863–70.10.1056/NEJMoa991159
   PubMed Web of Science ®Google Scholar
• Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, et al. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Clin Infect Dis. 2013;57:903–14.10.1093/cid/cit374
   PubMed Web of Science ®Google Scholar
• Siberry GK. Preventing and managing HIV infection in infants, children and adolescents in the United States. Pediatr Rev. 2014;35:268–86.10.1542/pir.35-7-268
   PubMedGoogle Scholar
• Haile-Selassie H, Townsend C, Tookey P. Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001–2008. HIV Med. 2011;12:422–7.10.1111/hiv.2011.12.issue-7
   PubMed Web of Science ®Google Scholar
• McKeegan K, Rutstein R, Lowenthal E. Postnatal infant HIV prophylaxis: a survey of U.S. practice. AIDS Patient Care and STDs. 2011;25:1–4.10.1089/apc.2010.0255
   PubMed Web of Science ®Google Scholar
• Cheng TL, Monteiro N, DiMeglio LA, Chien AT, Peeples ES, Raetz E, et al. Seven great achievements in pediatric research in the past 40 y. Pediatr Res. 2016;80:330–7.10.1038/pr.2016.95
   PubMed Web of Science ®Google Scholar
• Radin AK, Abutu AA, Okwero MA, Adler MR, Anyaike C, Asiimwe HT, et al. Confronting challenges in monitoring and evaluation: innovation in the context of the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. J Acquir Immune DeficSyndr. 2017;75:S66–S75.10.1097/QAI.0000000000001313
   PubMed Web of Science ®Google Scholar
• Reitter A, Stücker AU, Linde R, Königs C, Knecht G, Herrmann E, et al. Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort. HIV Med. 2014;15:525–36.10.1111/hiv.2014.15.issue-9
   PubMed Web of Science ®Google Scholar
• Mark S, Murphy KE, Read S, Bitnun A, Yudin MH. HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era. Infect Dis Obstet Gynecol. 2012.
   PubMedGoogle Scholar